arctigenin has been researched along with Depression in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aosai, F; Cheng, JH; Cui, YX; Jin, X; Li, J; Ma, J; Piao, HN; Piao, HR; Piao, LX; Xu, X; Zeng, XY | 1 |
| Chen, H; Du, Y; Gao, Y; Li, W; Li, Y; Shi, H; Velez de-la-Paz, OI; Wang, X; Yang, J; Yin, S; Yin, X | 1 |
2 other study(ies) available for arctigenin and Depression
| Article | Year |
|---|---|
Arctigenin protects against depression by inhibiting microglial activation and neuroinflammation via HMGB1/TLR4/NF-κB and TNF-α/TNFR1/NF-κB pathways.
Topics: Animals; Depression; Furans; HMGB1 Protein; Lignans; Mice; Microglia; NF-kappa B; Receptors, Tumor Necrosis Factor, Type I; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2020 |
Repeated arctigenin treatment produces antidepressant- and anxiolytic-like effects in mice.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Depression; Disease Models, Animal; Furans; Lignans; Male; Mice; Mice, Inbred ICR; Motor Activity; Ribonuclease, Pancreatic; Stress, Psychological; Thrombopoietin; Vascular Endothelial Growth Factor A | 2019 |